Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
<Results> Clover Biopharmaceuticals (02197.HK) Narrows Annual Loss to RMB205 Million
Recommend 6 Positive 3 Negative 4 |
||||
|
||||
|
Clover Biopharmaceuticals-B (02197.HK) announced its annual results for the year ended last December. The revenue was RMB3.505 million, representing a year-on-year decrease of 90.9%. The loss narrowed to RMB205 million, compared to a loss of RMB903 million in the same period last year; the loss per share was RMB0.16. No dividend was declared. Under non-IFRS standards, the adjusted loss narrowed from RMB887 million in the previous year to RMB198 million. (ca/da) Auto-translated by third-party software This translation was auto-generated by third-party software. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
Website: www.aastocks.com |
||||
Copied to Clipboard
 |
||||
